πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Essential Pharma Patents

Full USPTO pharma patent portfolio for Essential Pharma β€” grant dates, expiration, and drug cross-links.

Patents
95
Expiring ≀24m
2

Quick answer

Essential Pharma has 95 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Page 2 of 2

  1. US 9757384

    Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9675653

    Composition containing an essential oil product and method for using such to maintain normal levels of testosterone

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9648899

    Drinking water formulation and method and article relating to same

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9630931

    Pharmaceutically active pyrazine derivatives

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9420821

    Drinking water formulation and method and article relating to same

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9381202

    Salts of potassium ATP channel openers and uses thereof

    Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9307783

    Drinking water formulation and method and article relating to same

    Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9211277

    Dietary supplement composition

    Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9072675

    Non-irritating benzoyl peroxide

    Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9066904

    Composition containing an essential oil product and method for using such to maintain normal levels of testosterone

    Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8993627

    N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8937099

    N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8828979

    Salicylic acid gel

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8765933

    Asynthesis of Ξ²-nucleosides

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8716287

    Pharmaceutical compounds

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8716473

    Substituted benzotriazines and quinoxalines as inhibitors of P7OS6 kinase

    Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8697130

    Non-irritating benzoyl peroxide

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8679557

    Synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma

    Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8646461

    Device and method for simulating chemosensation of smoking

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8636988

    Composition for treatment of sunburned skin

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8617532

    Therapeutic use of interferon-polymer conjugates

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8609367

    Genes and proteins for the biosynthesis of the lantibiotic 107891

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8461339

    Pharmaceutical compounds

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8458818

    Elastomeric gloves and methods of making

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8273343

    Protein-polymer conjugates

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8193339

    Synthesis of Ξ²-nucleosides

    Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8178114

    Patch device for a fragrance and method of using the patch device

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8143214

    Protein-polymer conjugates

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8106160

    N-terminal modified interferon-alpha

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7964188

    Use of placental alkaline phosphatase to promote skin cell proliferation

    Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7923044

    Composition for high-ORAC value dietary supplement

    Expires Mon Apr 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7799777

    Salts of potassium ATP channel openers and uses thereof

    Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7718170

    Alkaline phosphatase compositions to reduce skin cancer

    Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7572789

    Salts of potassium ATP channel openers and uses thereof

    Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7557081

    Alpha-1-acid glycoprotein for the treatment of diabetes

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7374754

    Use of placental alkaline phosphatase to promote skin cell proliferation

    Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7312198

    Protein compositions for promoting wound healing and skin regeneration

    Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 6828351

    Methods and compositions for regulating memory consolidation

    Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6723716

    7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof

    Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6689782

    Fungal efflux pump inhibitors

    Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6599893

    Cephalosporin antibiotics and prodrugs thereof

    Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6596723

    Fungal efflux pump inhibitors

    Expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6495591

    Fungal efflux pump inhibitors

    Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6482921

    Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use

    Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6436980

    Peptidomimetic efflux pump inhibitors

    Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6197307

    Method for producing high activity extracts from harpagophytum procumbens

    Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6180105

    Method for producing an extract containing artemesinin

    Expires Mon Jan 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Essential Pharma have?

95 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Essential Pharma patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.